Related Experiment Video

Updated: May 5, 2026

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
05:55

Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System

Published on: December 21, 2019

6.1K

The inhibition of hepatitis B virus by APOBEC cytidine deaminases

E M Janahi1, M J McGarvey

  • 1Department of Biology, College of Science, University of Bahrain, Sakhir, Bahrain.

Journal of Viral Hepatitis
|December 6, 2013
PubMed

Insights

APOBEC3 (A3) enzymes fight viral infections like HIV-1 and HBV by damaging viral DNA. These innate immune proteins may also contribute to liver cancer development during chronic HBV infection.

Area of Science:

  • Immunology
  • Virology
  • Molecular Biology

Background:

  • APOBEC3 (A3) enzymes are key components of the innate immune system.
  • A3 proteins inhibit retroviral replication, including HIV-1.
  • A3s also target Hepatitis B Virus (HBV) DNA, impacting its replication.

Purpose of the Study:

  • To investigate the role of APOBEC3 enzymes in HBV replication and pathogenesis.
  • To understand the mechanisms by which A3 proteins inhibit HBV.
  • To explore the potential link between A3 proteins and hepatocellular carcinoma in chronic HBV infection.

Main Methods:

  • Analysis of A3 gene expression in response to interferon stimulation.
  • Investigating A3 incorporation into HBV capsids.
  • Assessing the impact of A3 activity on HBV DNA during replication.
  • Evaluating the effects of deaminase-deficient A3 proteins on HBV.

Main Results:

  • A3 gene expression is upregulated by interferons in liver cells.
  • A3 deaminases are incorporated into HBV capsids and modify viral DNA.
  • A3-mediated modifications include base conversion (cytidine to uracil) and G-to-A mutations, leading to DNA degradation or coding sequence disruption.
  • A3 proteins lacking deaminase activity also inhibit HBV replication, indicating multiple inhibitory mechanisms.

Conclusions:

  • APOBEC3 enzymes are potent inhibitors of HBV replication through direct DNA modification and potentially other mechanisms.
  • Interferon stimulation enhances A3 expression, suggesting a coordinated immune response against HBV.
  • A3 proteins may play a dual role in chronic HBV infection, contributing to viral control but also potentially to hepatocellular carcinoma development.

Keywords:
APOBECHBVdeaminationreplication

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.2K
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

6.6K

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
58
RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.3K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
4.8K